Optune HFE Transducer Arrays
Novocure, GmbH · Decision date Sep 16, 2026
What did the FDA decide?
The FDA record for P100034/S046 lists decision OK30 dated 2026-09-16 for a 30-day notice submitted by Novocure, GmbH. The stated change is a minor modification to the pallet configuration for the maximum load during gamma sterilization of HFE transducer arrays performed at Steris Schweiz. The supplement reason is given as a process change affecting the manufacturer, sterilizer, packager or supplier.
The S046 suffix ties this action to the original PMA P100034, consistent with a supplement rather than a new approval of the device or its indications. The submission describes the reported purpose of a packaging and sterilization process adjustment; it does not establish independent evidence of safety or clinical effectiveness, and the record supplies no detail on pallet geometry, loading limits, dose parameters or validation results. Those specifics are absent from the supplied fields.
FDA approval order statement
approval to implement a minor change to the pallet configuration for the maximum load during gamma sterilization process for the HFE arrays performed at Steris Schweiz
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Sep 16, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P100034/S046
- Regulatory pathway
- PMA supplement
- Applicant
- Novocure, GmbH
- Product code
- NZK
- Decision code
- OK30
- Decision date
- Sep 16, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, low electric field, tumor treatment.
- Applicant
- Novocure, GmbH
- Product code
- NZK
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P100034. Subsequent supplements may change the device or its indications.
FDA decision timeline
P100034 · Original PMA
NOVOCURE LTD'S NOVOTTF-100A TREATMENT KIT
P100034/S046 received
Application receipt date recorded by FDA.
P100034/S046 · FDA decision
30-Day Notice
P100034/S045 · Related supplement
Novocure GmbHs Optune Gio
Timeline entries are records held by MedtechLedger for P100034. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P100034
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Novocure, GmbH | PMA approval | Apr 8, 2011 | FDA | |
Novocure GmbHs Optune GioP100034/S045 | Novocure, GmbH | PMA supplement | Sep 18, 2026 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Novocure, GmbH
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Neuhofstrasse 21, Baar, 6340
Sources and methodology
- Original FDA record: P100034/S046
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records
